Senti Biosciences Inc. (SNTI)

3.00

-0.01 (-0.33%)

At close: Mar 03, 2025, 12:24 PM

Senti Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-71.06M	-58.22M	-55.32M	-19.86M	-21.16M
Depreciation & Amortization	5.43M	3.92M	3.01M	1.99M	1.4M
Stock-Based Compensation	9.67M	16.39M	2.29M	272K	205K
Other Working Capital	4.45M	13.85M	1.83M	165K	n/a
Other Non-Cash Items	-1.1M	-10.89M	14.74M	-5.03M	1.38M
Deferred Income Tax	n/a	n/a	22K	235K	-329K
Change in Working Capital	4.67M	13.9M	615K	-1.77M	124K
Operating Cash Flow	-52.4M	-34.9M	-34.63M	-24.17M	-18.38M
Capital Expenditures	-12.04M	-41.37M	-5.54M	-1.16M	-2M
Acquisitions	n/a	n/a	n/a	-12.52M	n/a
Purchase of Investments	-17.99M	-40.59M	n/a	-446K	n/a
Sales Maturities Of Investments	60M	n/a	n/a	12.96M	n/a
Other Investing Acitivies	105K	-40.59M	n/a	12.52M	5.75M
Investing Cash Flow	30.08M	-81.96M	-5.54M	11.36M	3.75M
Debt Repayment	-108K	5.17M	n/a	8M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	375K	112.65M	68.44M	30.05M	14.01M
Financial Cash Flow	779K	118.55M	68.44M	38.05M	14.01M
Net Cash Flow	-21.54M	1.7M	28.26M	25.24M	5.8M
Free Cash Flow	-64.43M	-76.27M	-40.18M	-25.33M	-20.37M